alanine has been researched along with dalteparin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferguson, JJ | 1 |
| Sheehan, JP; Walke, EN; Yuan, QP | 1 |
| Baker-Deadmond, KJ; Nalian, A; Neuenschwander, PF; Williamson, SR | 1 |
| Cloonan, ME; DiNapoli, M; Mousa, SA | 1 |
| Atzori, L; Bandino, F; Carta, F; Chuchueva, N; Fanos, V; Lussu, M; Noto, A; Peppi, M; Puxeddu, R | 1 |
5 other study(ies) available for alanine and dalteparin
| Article | Year |
|---|---|
Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology.
Topics: Abciximab; Alanine; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Benzamidines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Disease; Dalteparin; Defibrillators, Implantable; Double-Blind Method; Enalapril; Endothelial Growth Factors; Fatty Acids, Omega-3; Guanidines; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Laser Therapy; Lymphokines; Metoprolol; Multicenter Studies as Topic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pyrrolidines; Randomized Controlled Trials as Topic; Simvastatin; Sodium-Hydrogen Exchangers; Stents; Sulfones; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E | 1999 |
The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
Topics: Alanine; Antithrombins; Binding Sites; Blood Coagulation Tests; Cell Line; Chromogenic Compounds; Coenzymes; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dalteparin; Factor IXa; Factor VIIIa; Factor X; Half-Life; Humans; Hydrolysis; Kinetics; Mutagenesis, Site-Directed; Neoplasm Proteins; Protein Binding | 2005 |
Heparin modulates the 99-loop of factor IXa: effects on reactivity with isolated Kunitz-type inhibitor domains.
Topics: Alanine; Allosteric Site; Aprotinin; Cell Line; Enoxaparin; Factor IXa; Heparin; Humans; Kinetics; Models, Chemical; Mutation; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary | 2006 |
Efficacy of anticoagulants and platelet inhibitors in cancer-induced thrombosis.
Topics: Alanine; Cell Line, Tumor; Drug Therapy, Combination; Enoxaparin; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Oxazoles; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombelastography; Thromboplastin; Thrombosis; Tinzaparin | 2007 |
Metabolomic analysis of urine with Nuclear Magnetic Resonance spectroscopy in patients with idiopathic sudden sensorineural hearing loss: A preliminary study.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Aged; Alanine; Anticoagulants; Audiometry, Pure-Tone; Case-Control Studies; Child; Citric Acid; Cohort Studies; Creatinine; Enoxaparin; Female; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Immunosuppressive Agents; Male; Metabolomics; Methylamines; Middle Aged; Pregnenediones; Prognosis; Prospective Studies; Proton Magnetic Resonance Spectroscopy; Urine; Young Adult | 2017 |